相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1-or Melan-A-Specific T Cells
Benjamin Weide et al.
CLINICAL CANCER RESEARCH (2014)
Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Increase in CD14+HLA-DR-/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
Fumitaka Arihara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
Suresh Kalathil et al.
CANCER RESEARCH (2013)
Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow
Indu R. Ramachandran et al.
JOURNAL OF IMMUNOLOGY (2013)
Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer
Chris P. Verschoor et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
Paola Filipazzi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy
Nicolo Rigamonti et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
On the armament and appearances of human myeloid-derived suppressor cells
Isabel Poschke et al.
CLINICAL IMMUNOLOGY (2012)
Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples
Athanasios Kotsakis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells
Chun-Te Wu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Steffen Walter et al.
NATURE MEDICINE (2012)
Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells
Bastian Hoechst et al.
BLOOD (2011)
Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α
Caroline Hasselbalch Riley et al.
BLOOD (2011)
Increased Circulating Immunosuppressive CD14+HLA-DR-/low Cells Correlate with Clinical Cancer Stage and Pathological Grade in Patients with Bladder Carcinoma
X-K Yuan et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
IL-6/IL-6R as a potential key signaling pathway in prostate cancer development
Andreia Azevedo et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2011)
Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
Isabel Poschke et al.
CANCER RESEARCH (2010)
High Expression of IMPACT Protein Promotes Resistance to Indoleamine 2,3-Dioxygenase-Induced Cell Death
Darya Habibi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Philip W. Kantoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
Laurence Klotz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Critical parameters in blood processing for T-cell assays: Validation on ELISpot and tetramer platforms
Georgia Afonso et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone
Michael P. Gustafson et al.
NEURO-ONCOLOGY (2010)
Immunosuppressive CD14+HLA-DRlow/- Monocytes in Prostate Cancer
Stanimir Vuk-Pavlovic et al.
PROSTATE (2010)
Correlation Between Serum Prostate-specific Antigen and Cancer Volume in Prostate Glands of Different Sizes
Gustavo F. Carvalhal et al.
UROLOGY (2010)
CD49d provides access to untouched human Foxp3+ Treg free of contaminating effector cells
Markus Kleinewietfeld et al.
BLOOD (2009)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko et al.
CLINICAL CANCER RESEARCH (2009)
Pretreatment frequency of circulating IL-17+CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients
Evelyna Derhovanessian et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Regulation of immune responses by L- arginine metabolism
V Bronte et al.
NATURE REVIEWS IMMUNOLOGY (2005)
The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age
R Gregg et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
V Bronte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Regulation of T cell receptor CD3 chain expression by L-arginine
PC Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Recovery of ζ-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer
N Meidenbauer et al.
BRITISH JOURNAL OF CANCER (2002)